The ADAs 2026 update discusses GLP-1 RA effects on eye health including potential impacts on diabetic retinopathy progression, glaucoma, and macular degeneration
KFF data showed two-thirds of state Medicaid programs said cost was a decision factor when determining coverage of GLP-1 drugs
newer formulations (e.g., liposomal) may have better absorption but still need evidence
In a mouse model of inflammation, the decrease of LPS-induced paw edema by DATS was associated with reduced serum concentrations of the pro-inflammatory cytokines, TNF-, IL-6, and monocyte chemotactic protein-1 (MCP-1) (36)
By stimulating growth hormone release, these peptides may influence fat breakdown, providing insights into their potential use in metabolic research